Who Exports Metronidazole from India — 962 Suppliers Behind a $202.0M Market
India's metronidazole export market is supplied by 962 active exporters who collectively shipped $202.0M across 13,685 shipments. MEDOPHARM leads with a 21.4% market share, followed by UNICHEM LABORATORIES LIMITED and OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED. The top 5 suppliers together control 47.0% of total export value, reflecting a moderately competitive market structure.
Top Metronidazole Exporters from India — Ranked by Export Value
MEDOPHARM is the leading metronidazole exporter from India, holding a 21.4% share of the $202.0M market across 13,685 shipments from 962 exporters. The top 5 suppliers — MEDOPHARM, UNICHEM LABORATORIES LIMITED, OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, LINCOLN PHARMACEUTICALS LTD — collectively control 47.0% of total export value, indicating a competitive market. Individual shares are: MEDOPHARM (21.4%), UNICHEM LABORATORIES LIMITED (14.6%), OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED (3.9%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (3.6%), LINCOLN PHARMACEUTICALS LTD (3.5%).
Top Metronidazole Exporters from India
Ranked by export value · 962 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MEDOPHARM METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE POWDER FOR ORAL SUSPENSION | $43.3M | 25 | 21.4% |
| 2 | UNICHEM LABORATORIES LIMITED METRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE 500MG TABLETS 100T USPMETRONIDAZOLE CAPS 375MG 50C AP USNOS | $29.4M | 2 | 14.6% |
| 3 | OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE TABLETS BP 250MGMETRONIDAZOLE TABLETS 200MG EACH TABLET | $7.9M | 52 | 3.9% |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE TABLETS BP 500MG (TOPGYL 5MET TARA IV METRONIDAZOLE 500MG /100ML B | $7.3M | 17 | 3.6% |
| 5 | LINCOLN PHARMACEUTICALS LTD METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE POWDER FOR ORAL SUSPENSIONHARMLESS MEDICINES-METRONIDAZOLE POWDER | $7.0M | 14 | 3.5% |
| 6 | ALEMBIC PHARMACEUTICALS LIMITED METRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE 500MG TABLETS 100T USPMETRONIDAZOLE CAPS 375MG 50C AP USNOS | $5.3M | 1 | 2.6% |
| 7 | AMANTA HEALTHCARE LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XPHARMACEUTICAL PRODUCTS, METRONIDAZOLE IMETRONIDAZOLE TABLETS BP 250MG | $4.4M | 16 | 2.2% |
| 8 | BIOMATRIX HEALTHCARE PRIVATE LIMITED METRONIDAZOLE TABLETS BP 500MG (TOPGYL 5METRONIDAZOLE TABLETS BP 250MGMETRONIDAZOLE TABLETS BP 200MG. (SR.NO.1 | $3.1M | 7 | 1.6% |
| 9 | ACULIFE HEALTHCARE PRIVATE LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE POWDER FOR ORAL SUSPENSIONPHARMACEUTICAL PRODUCTS, METRONIDAZOLE I | $3.0M | 32 | 1.5% |
| 10 | ZYDUS LIFESCIENCES LIMITED METRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE POWDER FOR ORAL SUSPENSIONMETRONIDAZOLE 500MG TABLETS 100T USP | $2.6M | 4 | 1.3% |
| 11 | GLENMARK PHARMACEUTICALS LIMITED METRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE 500MG TABLETS 100T USPMETRONIDAZOLE CAPS 375MG 50C AP USNOS | $2.4M | 1 | 1.2% |
| 12 | AGOG PHARMA LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE TABLETS 200MG EACH TABLETAARTROGYL 200MG TABLETS PACK SIZE:10X10 S | $2.4M | 3 | 1.2% |
| 13 | S KANT HEALTHCARE LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE 500MG TABLETS 500T USPMETRONIDAZOLE POWDER FOR ORAL SUSPENSION | $2.3M | 14 | 1.1% |
| 14 | CAPLIN POINT LABORATORIES LIMITED METRONIDAZOLE POWDER FOR ORAL SUSPENSIONMETRONIDAZOLE INTRAVENOUS INFUSION BP 50 | $2.2M | 10 | 1.1% |
| 15 | YELURI FORMULATIONS PRIVATE LIMITED METRONIDAZOLE TABLETS BP 200MG (230000 XMETRONIDAZOLE TABLETS BP 250MGHARMLESS MEDICINES-METRONIDAZOLE POWDER | $2.1M | 6 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Metronidazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Warning Letter, July 2025 | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Pithampur facility. |
| Zydus Lifesciences Limited | Not Listed | Unknown | Unknown | Not verified | Zydus recalled products in the US due to manufacturing issues, as per USFDA repo |
| Unichem Laboratories Limited | Not Listed | Unknown | Unknown | Not verified | Unichem recalled products in the US due to manufacturing issues, as per USFDA re |
| Alembic Pharmaceuticals Limited | Not Listed | Unknown | Unknown | Not verified | Alembic recalled products in the US due to manufacturing issues, as per USFDA re |
| Sun Pharmaceutical Industries Limited | Not Listed | Unknown | Unknown | Not verified | Sun Pharma recalled products in the US due to manufacturing issues, as per USFDA |
TransData Nexus reviewed the regulatory standing of 5 leading Metronidazole exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Metronidazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its production of active pharmaceutical ingredients (APIs). Companies like Aurobindo Pharma, headquartered in Hyderabad, exemplify this specialization. Aurobindo Pharma is a significant player in the pharmaceutical industry, focusing on the manufacturing of generic pharmaceuticals and APIs. The city's robust infrastructure and skilled workforce make it a pivotal hub for API production, including Metronidazole.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a major center for pharmaceutical formulations. Companies such as Cadila Pharmaceuticals, headquartered in Ahmedabad, have a strong presence in this region. Cadila Pharmaceuticals focuses on manufacturing a range of products, including APIs and finished formulations. The region's emphasis on formulations complements the API production in other clusters, facilitating a comprehensive supply chain for drugs like Metronidazole.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceuticals. Companies like Cipla, headquartered in Mumbai, have a significant presence in this area. Cipla is an Indian multinational pharmaceutical company that focuses on developing medications to treat various medical conditions. The proximity to major ports and international airports enhances the region's capacity to distribute pharmaceuticals globally, including Metronidazole.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, largely due to favorable tax incentives. This region attracts numerous pharmaceutical companies seeking cost-effective production solutions. The tax benefits and supportive infrastructure have led to the establishment of various manufacturing units, contributing to the production of drugs like Metronidazole.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with manufacturers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical expertise and regulatory compliance of potential suppliers to ensure consistent product quality.
- Leverage Export Hubs: Utilize the logistical advantages of regions like Mumbai-Thane-Raigad for efficient international distribution.
- Monitor Regulatory Changes: Stay informed about tax incentives and regulatory developments in clusters like Baddi-Nalagarh to optimize sourcing strategies.
By strategically sourcing Metronidazole from India's specialized pharmaceutical clusters, companies can enhance supply chain resilience and ensure product quality.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Metronidazole exporters from India
Unichem Laboratories Limited — Ipca Laboratories to integrate Bayshore Pharmaceuticals into Unichem Pharma USA
Ipca Laboratories' board discussed the strategic integration of Bayshore Pharmaceuticals' generics business into Unichem Pharmaceuticals (USA) Inc. This move aims to enhance Unichem's market presence and streamline operations in the U.S. market. - IMPACT: Potential to strengthen Unichem's Metronidazole export capabilities through expanded U.S. operations.
Impact: Potential to strengthen Unichem's Metronidazole export capabilities through expanded U.S. operations.
J B Chemicals & Pharmaceuticals Limited — Torrent Pharmaceuticals to acquire controlling stake in JB Chemicals
Torrent Pharmaceuticals announced the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from investment firm KKR for an equity valuation of ₹25,689 crore. The deal includes a cash purchase of 46.39% equity, a mandatory open offer to public shareholders, and plans to merge JB Pharma into Torrent. - IMPACT: This acquisition is expected to bolster Metronidazole exports by leveraging combined resources and market reach.
Impact: This acquisition is expected to bolster Metronidazole exports by leveraging combined resources and market reach.
Lupin Limited — Lupin appoints new CEO to lead CDMO expansion
Lupin announced the appointment of Abdelaziz Toumi as the new CEO of its subsidiary Lupin Manufacturing Solutions (LMS). Toumi's extensive experience in the active pharmaceutical ingredient CDMO field is expected to position LMS as a trusted partner for global clients. - IMPACT: While not directly related to Metronidazole, Lupin's CDMO expansion may influence the competitive landscape for Metronidazole exports.
Impact: While not directly related to Metronidazole, Lupin's CDMO expansion may influence the competitive landscape for Metronidazole exports.
Common Questions — Metronidazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which metronidazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MEDOPHARM leads with 141 recorded shipments worth $43.3M. UNICHEM LABORATORIES LIMITED (233 shipments) and OTSUKA PHARMACEUTICAL INDIA PRIVATE LIMITED (490 shipments) are also established high-volume exporters.
Q How many metronidazole manufacturers are there in India?
India has 962 active metronidazole exporters with a combined export market of $202.0M across 13,685 shipments to 182 countries. The top 5 suppliers hold 47.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for metronidazole from India?
Average FOB unit price: $4.45 per unit, ranging from $0.00 to $13683.25. Average shipment value: $14.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 962 verified Indian exporters of Metronidazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 13,685 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 182 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13,685 Verified Shipments
962 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists